PRESS RELEASE March 1 , 202 2 Saniona (OMX: SANION), a clinical - stage biopharmaceutical company focused on rare diseases, today announced that it will present at multiple upcoming investor conferences. Details are as follows: Redeye Investor Forum – Göteborg, Sweden Date/Time: 10 March 2022, 1:00